Smart multi-target drugs are redefining how we treat complex diseases by combining AI-driven discovery with mechanistic ...
The agency is proposing that drugmakers use shorter non-rodent studies and other sources of evidence when developing monoclonal antibodies for non-cancer settings.
The "Rising Stars in Drug Metabolism and Transport 2025/2026" highlights the groundbreaking work of early-career researchers ...
Ginkgo Datapoints has launched the Virtual Cell Pharmacology Initiative (VCPI), an open-source effort to create the first standardized framework for virtual cell modeling in drug discovery. By ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results